Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well as, pressure on operating performance as key drags. Despite near-term headwinds, most brokerage firms maintained their rating and target prices but slashed earnings per share (EPS) estimates for FY23-24.
Violent crypto attacks rise as criminals hunt bigger payouts
Physical attacks targeting cryptocurrency holders surged 33% globally in the first half of 2026, with losses soaring to $124 million. France emerged as the epicentre